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Background: Highly pathogenic avian influenza (HPAI) H5N1 viruses continue to circulate in poultry and can infect
and cause mortality in birds and mammals; the genetic determinants of their increased virulence are largely
unknown. The main purpose of this work was to determine the correlation between known molecular
determinants of virulence in different avian influenza virus (AIV) genes and the results of experimental infection of
birds and mammals with AIV strain A/swan/Mangistau/3/06 (H5N1; SW/3/06).
Methods and results: We examined the virulence of SW/3/06 in four species of birds (chickens, ducks, turkeys,
geese) and five species of mammals (mice, guinea pigs, cats, dogs, pigs), and identified the molecular determinants
of virulence in 11 genes (HA, NA, PB1, PB1-F2, PB2, PA, NS1, NS2, M1, M2 and NP). SW/3/06 does not possess the
prime virulence determinant of HPAIV – a polybasic HA cleavage site – and is highly pathogenic in chickens. SW/3/
06 replicated efficiently in chickens, ducks, turkeys, mice and dogs, causing 100% mortality within 1.6–5.2 days. In
addition, no mortalities were observed in geese, guinea pigs, cats and pigs. The HI assay demonstrated all not
diseased animals infected with the SW/3/06 virus had undergone seroconversion by 14, 21 and 28 dpi. Eleven
mutations in the seven genes were present in SW/3/06. These mutations may play a role in the pathogenicity of
this strain in chickens, ducks, turkeys, mice and dogs. Together or separately, mutations 228S-103S-318I in HA may
play a role in the efficient replication of SW/3/06 in mammals (mice, dogs, pigs).
Conclusions: This study provides new information on the pathogenicity of the newly-isolated swan derived H5N1
virus in birds and mammals, and explored the role of molecular determinants of virulence in different genes; such
studies may help to identify key virulence or adaptation markers that can be used for global surveillance of viruses
threatening to emerge into the human population.
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Influenza A viruses have eight-segmented, negative, single-
stranded RNA genomes and are serologically divided into
18 hemagglutinin (HA, H1-H18) and eleven neuraminidase
(NA, N1-N11) subtypes [1,2]. All known influenza A virus
subtypes has been isolated from a number of species in-
cluding humans, wild and domesticated birds, pigs, horses
and sea mammals [3], and there is evidence of transmission
to domestic dogs and cats [4]. The genome of influenza
A viruses consists of eight unique segments of single-
stranded, negative, sense RNA. The viral RNA segments
encode ten recognized gene products: the polymerases* Correspondence: tabynov777@mail.ru
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unless otherwise stated.PB1, PB2 and PA, and the proteins HA, NP, NA, M1, M2,
NS1 and NS2 [3,5].
Viruses typically acquire critical alterations in their ge-
nomes that allow them to adapt to or severely damage
their host. Identification of these genetic changes will
improve our understanding of the determinants of viru-
lence and aid in the development of counter measures
against viral infection and spread [6]. A number of gen-
etic determinants are associated with the virulence and
ability of avian influenza viruses (AIVs) to replicate
in mammalian cells [7]. Examination of the molecular
mechanisms responsible for the adaptation of AIVs from
natural reservoirs to new hosts is important for under-
standing the evolution of influenza viruses. The switch
in host cell receptor specificity from sialic acid con-
nected to galactose via α2-3 linkages (avian) to α2-6l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Tabynov et al. Virology Journal 2014, 11:207 Page 2 of 13
http://www.virologyj.com/content/11/1/207linkages (mammalian) is a major obstacle that prevents
AIVs from crossing the species barrier and adapting to
new hosts [8].
Three influenza viral proteins, PB2, HA and NS1, are
recognized as major determinants of virulence, patho-
genicity and host range restriction [9,10]. HA cleavage is
critical for virulence, as it exposes the hydrophobic N-
terminus of HA2, which mediates fusion of the viral and
endosomal membranes. The HA proteins of all highly
pathogenic avian influenza (HPAI) H5N1 viruses contain
multiple basic amino acids at their cleavage site [5]. The
NS1 protein plays an important role in countering host
cell antiviral cytokines and the initial host immune re-
sponse in chickens and cattle [11,12]. Recently, it was
shown that the amino acids at position 627 [13,14] and
701 [15,16] of the polymerase subunit PB2 and 97, 349
and 550 of the polymerase subunit PA [17,18] may play
important roles in the adaptation of HPAI H5N1 viruses
from birds to mammals.
Several studies have shown that mouse-adapted influ-
enza A and B viruses possess unique modifications in a
short stretch of the C-terminal domain of the M1 pro-
tein [19-21]. The M1 protein contributes to the viru-
lence of HPAI H5N1 viruses in mammalian hosts; the
amino acids Asp at position 30 and Ala at position 215
are necessary for the lethality of H5N1 viruses in mice
[22]. In addition to the polybasic HA cleavage site, the
caspase cleavage motif of the M2 protein and deletions
within the stalk region of NA are associated with in-
creased virulence of HPAI H5N1 viruses [23-25].
Continuing outbreaks of HPAI H5N1 world-wide em-
phasize the importance of full genetic characterization of
different viral strains from a variety of countries, as well as
pathogenicity studies in a range of animal species. The
present study examined the correlation between known
and novel molecular determinants of virulence in influ-
enza genes with the results of experimental infection of
birds (chickens, ducks, geese, turkeys) and mammals
(mice, guinea pigs, cats, dogs, pigs) with the AIV strain A/
swan/Mangistau/3/06 (H5N1; SW/3/06) that was isolated
in 2006 from a dead swan found in the Mangistau region
of the Republic of Kazakhstan. Identification of genetic de-
terminants of virulence will help to provide to a better un-
derstanding of the mechanisms involved in influenza virus
transmission and assist in pandemic preparedness.
Results
Epidemiology
In March 2006, mass wild bird mortalities were recorded
on the coast of the Caspian Sea. As part of the investiga-
tion into this outbreak, staff from the Research Institute
for Biological Safety Problems (RIBSP) selected 12 samples
of pathological material (trachea, lung, intestine, brain)
from three dead mute swans found on Cape Peschannyi,70 km from the city of Aktau in the Mangistau region of
Kazakhstan [26].
Analysis demonstrated that AIV A/H5N1 was the
cause of death in the mute swans. The viral strain SW/
3/06 was isolated from 10-day-old specific pathogen-free
(SPF) embryonated chicken eggs (ECEs); molecular
markers of pathogenicity associated with HPAI H5N1
were not present in the HA and NA surface proteins of
this strain (the HA proteolytic cleavage site contains an
amino acid sequence characteristic of low pathogenicity
influenza viral strains) [26]. Nevertheless, the intraven-
ous pathogenicity index (IVPI) of strain SW/3/06 in
chickens was 2.34, indicating that the strain is a highly
pathogenic [27]. This generated further interest in the
study of the virulence of strain SW/3/06 in different spe-
cies of birds and mammals, along with discovery of its
molecular determinants of virulence.
Genetic and phylogenetic analysis
The genotype of the HA gene of strain SW/3/06 (clade
EA-nonGsGD) differs from that of strains previously iso-
lated in Kazakhstan: A/domestic goose/Pavlodar/1/05
(H5N1; GS/1/05) and A/chicken/Astana/6/05 (H5N1;
CK/6/05) related to clade 2.2 of the Qinghai genotype
[28]. Strain SW/3/06 demonstrated antigenic shift; the
virus did not react with the antisera of the strains iso-
lated in Kazakhstan in 2005 [29], suggesting SW/3/06 is
probably a reassortant strain of AIVs circulating in the
Russian Far East and Japan as the highest degree of HA
amino acid sequence homology was identified with
strains A/duck/Hokkaido/vac-1/04 (H5N1) and A/duck/
Primorie/2633/01 (H5N3), for which the percentage
homology reached 96% [26,30].
This work established that the HPAI A/H5N1 viruses
isolated in Kazakhstan have different NS genotypes. The
strains isolated in 2005 (GS/1/05, CK/6/05) is referred to
as the Qinghai genotype NS1E, whereas SW/3/06 has a
NS2A genotype, which is typical of Gs/Gd-like strains
[31]. On the basis of these results, Chervyakova et al.
[31] suggested that strain SW/3/06 entered Kazakhstan
from Europe (Sweden) via the Black Sea/Mediterranean
migration routes of birds.
Virus replication in experimentally-inoculated birds and
mammals
Virulence and pathogenesis of A/swan/Mangistau/3/06 in
different avian species
AIVs that kill 75% or more of eight intravenously (i.v.) in-
oculated chickens within 10 days are classified as highly
pathogenic [32,33]. Inoculation of 4-week-old chickens
with SW/3/06 virus led to 100% mortality (IVPI =2.34)
within 3.3 days (Table 1).
Intranasal (i.n.) or intramuscular (i.m) inoculation of
chickens, ducks and turkeys with 104.3 EID50 of SW/3/








Antibody titer on indicated day post-infectionc
14 21 28
White Leghorns (i.v.) 10/10 3.3 104.3 ND ND ND
White Leghorns (i.n.) 6/6 3.4 104.3 ND ND ND
White Leghorns (i.m.) 6/6 3.6 104.3 ND ND ND
Kholmogory geese (i.n.) 0/6 >28.0 104.3 4.7 ± 0.6 6.0 ± 0.0 7.0 ± 1.0
Kholmogory geese (i.m.) 0/6 >28.0 104.3 4.3 ± 0.6 5.3 ± 0.6 6.0 ± 0.0
Silver Bantam ducks (i.n.) 6/6 4.2 104.3 ND ND ND
Silver Bantam ducks (i.m.) 6/6 5.2 104.3 ND ND ND
Czech turkeys (i.n.) 6/6 1.6 104.3 ND ND ND
Czech turkeys (i.m.) 6/6 1.8 104.3 ND ND ND
aNumber of birds that died/number of birds inoculated.
bDetermined by back titer determination of the inoculum; EID50, 50% egg infectious dose.
cPresented as Log2 HI titer ± standard deviation. Antibody titers were determined by an HI assay of two-fold diluted serum.
ND, not determined.
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death times (MDTs) of chickens and ducks (3.4-3.6 and
4.2-5.2 days) were longer than that of i.v. inoculated
chickens [27]. The MDT for i.n. and i.m. inoculated
turkeys were shorter (1.6-1.8 days) than the other ex-
perimental groups of birds. In addition, no mortalities or
clinical signs of disease were observed in geese i.n. or i.
m. infected with SW/3/06, with seroconversion observed
at 14, 21 and 28 days post-infection (dpi; Table 1).
The SW/3/06 virus replicated and was shed from both
the gastrointestinal and respiratory tracts of chickens, as
indicated by the relatively high titers (3.6 to 5.2 log10
EID50/mL) of virus recovered from oropharyngeal and clo-
acal swabs (Figure 1). Furthermore, high AIV titers were
also detected in kidney and brain tissues, as well as the
lungs (5.7 to 8.2 log10 EID50/g of tissue). The tissue andFigure 1 Mean titers of SW/3/06 virus recovered from different avian
inoculated i.n. or i.m. with 104.3 EID50/50 μl of SW/3/06 virus. Viral titers wer
samples and EID50 per ml for tracheal and cloacal swabs. The limits of virus
and 0.75 log10 EID50, respectively (*P <0.05, **P <0.01, ***P <0.001; two-wayswab viral titers were similar for both i.v., i.n. and i.m. in-
oculated chickens. SW/3/06 virus also grew rapidly in tur-
keys, as demonstrated by high viral titers in brain, kidney
and lung tissues (6.8 to 7.7 log10 EID50/g) as well as oro-
pharyngeal and cloacal swabs (4.3 to 5.0 log10 EID50/mL).
Compared to chickens and turkeys, significantly lower
virus accumulation was observed in the internal organs of
the gastrointestinal and respiratory tracts of ducks and
geese (from P <0.01 to P <0.001), and the SW/3/06 virus
was not detected in the brains of any geese (< 101.75
EID50/g; Figure 1). This study showed that geese shed the
virus without exhibiting any clinical signs.
Virus replication and pathogenicity in mice
Five 5 to 6-week-old SPF female BALB/c mice (per
group) were i.n. or i.m. inoculated with SW/3/06 virusspecies. Chickens, ducks, turkeys and geese (six per group) were
e determined in ECEs and expressed as EID50 per gram for tissue
detection (horizontal dotted lines) for tissues and swabs were 1.75
ANOVA followed by Tukey's multiple comparisons test).
Figure 2 Survival curves for mice inoculated with the SW/3/06
virus. Female 5-week-old BALB/c mice (five per group) were inoculated
i.n. or i.m. with 104.0 EID50/50 μl of the SW/3/06 virus. Although they had
equivalent mortality rates (100%), the i.m. inoculated group had
significantly longer survival than the i.n. inoculated group (log-rank test,
P =0.0005).
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bidity and mortality in mice. The infected mice displayed
severe clinical signs, including ruffled fur, depression
and labored breathing. All five mice in both groups died
within 2.4-2.8 dpi (Table 2) with significantly longer sur-
vival observed in the i.m. inoculated group than the i.n.
inoculated group (Figure 2; log-rank test, P =0.0005).
Katz et al. [34] established that AIVs with a mouse lethal
dose (MLD50) > 10
6.5 were considered to have low patho-
genicity, while MLD50 < 10
3.0 were considered highly
pathogenic in mouse models. The MLD50 of the SW/3/
06 virus was < 103.0 EID50 (Table 3); therefore, this virus
is highly pathogenic in mice.
To assess virus replication, we collected various organs
such as lung, brain, liver, spleen and kidney from three
dead mice in each group (inoculated with 104.0 EID50 of
SW/3/06 virus) and titrated virus replication in ECEs.
The inoculated virus was recovered from all tested or-
gans (mean viral titers, 101.8 to 106.4 EID50/0.1 mL) with
no significant differences between the i.n. and i.m. inoc-
ulated groups (P =0.5130; Table 3). These results dem-
onstrate that mice are highly susceptible to strain of
SW/3/06 AIV.
Pathogenicity in dogs
The replication and virulence of the SW/3/06 virus were
assessed in eight-week-old SPF beagles. Two groups of
three dogs lightly anesthetized with ketamine were i.n.
or intratracheally (i.t.) inoculated with 1 mL of 104.6
EID50 of SW/3/06 virus. Nasal and rectal swabs were
collected from the infected dogs on day 2 post-infection








BALB/c mice (i.n.) 5/5 2.4 104.0
BALB/c mice (i.m.) 5/5 2.8 104.0
Guinea pigs (i.n.) 0/5 >14.0 104.3
Guinea pigs (i.m.) 0/5 >14.0 104.3
Guinea pigs (i.n.) 0/3 >14.0 106.0
Guinea pigs (contact) 0/3 >14.0 –
Large White pigs (i.n.) 0/5 >14.0 105.3
Large White pigs (i.m.) 0/5 >14.0 105.3
Scottish Fold cats (i.n.) 0/3 >14.0 104.6
Scottish Fold cats (i.t.) 0/3 >14.0 104.6
Beagle dogs (i.n.) 3/3 2.3 104.6
Beagle dogs (i.t.) 3/3 4.7 104.6
aNumber of mammals that died/number of mammals inoculated.
bDetermined by back titer determination of the inoculum; EID50, 50% egg infectiou
cPresented as Log2 HI titer ± standard deviation. Antibody titers were determined b
ND, not determined.three dead animals in each group for assessment of virus
replication and pathological analysis. All six dogs be-
came anorexic on day 1 post-infection and completely
lost their appetites. All animals developed fever around
24 h post-infection, and their temperature declined be-
tween 48 and 72 h (i.n.) or 96 and 120 h (i.t.) post-
infection (Figure 3A). Conjunctivitis, diarrhea, cough
and labored breathing were observed in all three animals
in both groups. All animals died within 2.3-4.7 dpi
(Table 2) with significantly longer survival observed in
the i.t. inoculated group than the i.n. inoculated group
(Figure 3B; log-rank test, P =0.0065).
To investigate whether the inoculated dogs shed the
virus, swabs titrated in ECEs. As shown in Figure 4, the
virus was detected from the nasal and rectal swabs of all
three animals in the i.n. and i.t. inoculated groups. Thealian species




5.0 ± 1.0 5.3 ± 0.6 5.7 ± 0.6
4.7 ± 1.1 4.7 ± 0.6 5.3 ± 0.6
5.0 ± 0.0 5.7 ± 0.6 6.0 ± 0.0
< 1.0 < 1.0 < 1.0
3.7 ± 0.6 4.0 ± 0.0 4.7 ± 0.6
3.0 ± 0.0 3.3 ± 0.6 4.0 ± 0.0
7.0 ± 1.0 8.3 ± 1.1 8.7 ± 0.6




y an HI assay of two-fold diluted serum.





Hpi Viral titer (log10 EID50/0.1 mL, mean ± standard deviation) MLD50
(EID50)
MID50
(EID50)Lung Brain Liver Spleen Kidney
I.n. 104.0 30-48 6.4 ± 0.7 1.9 ± 0.1 2.7 ± 0.6 4.2 ± 1.0 4.1 ± 0.8 2.9 1.7
I.m. 104.0 48-72 6.2 ± 0.8 1.8 ± 0.1 2.0 ± 0.4 3.6 ± 0.5 3.5 ± 1.5
BALB/c mice (five per group) were inoculated intranasally or intramuscularly with 104.0 EID50/50 μl of SW/3/06 virus. To assess mouse LD50 (MLD50), the mice were
inoculated with 10-fold serial dilutions of 106.0 EID50 of SW/3/06 virus (10
0.0 to 107.0) via the intranasal route and observed for 14 days. To assess mouse ID50
(MID50), lung tissues were collected from three inoculated mice per group at 3 dpi. The lower virus detection limit was 10
1.75 EID50/g.
Hpi, hour post infection.
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i.n. group than i.t. group (P <0.05; Figure 4). In both
groups, high viral titers were observed in the lung, tonsil
and trachea, and low titers in the lymph nodes (P <0.001;
Figure 4); the virus was not detected in the brain. These
results indicate the SW/3/06 virus can replicate efficiently
in dogs inoculated i.n. or i.t.
Macroscopic lung lesions were detected in all six dogs.
Multifocal hemorrhages were observed in the lungs of
all dogs inoculated i.n. (Figure 5A) and i.t. (Figure 5B).
The area of multifocal hemorrhage was more pro-
nounced in the lungs of i.n. infected dogs than i.t. in-
fected dogs. Prominent swelling of extrapulmonary
organs and hyperemia of the tonsils were observed in all
dogs. These results demonstrate that dogs are highly
susceptible to strain of SW/3/06 AIV.Pathogenicity in cats
Groups of 8–12-week-old cats were inoculated i.n. (n =5)
or i.t. (n =5) with 104.6 EID50 of the SW/3/06 virus. Five
other cats were mock-infected with PBS as controls. No
clinical abnormalities were observed in any group; the
body temperature of cats inoculated i.n. or i.t. remained
within physiological norms (data not shown). Virus was
not isolated from any tissues or swabs (data not shown).
However, cats inoculated i.n. or i.t. with the SW/3/06 virus
had seroconverted at 14, 21, 28 dpi, and the HI assay dem-
onstrated the serum contained high levels of antibodies
against subtype H5 AIVs (Table 2). These results indicateFigure 3 Body temperature and survival curves of dogs inoculated w
(three per group) were inoculated i.n. or i.t. with 104.6 EID50/mL of the SW/
(B) Survival curves. Although they had equivalent mortality rates (100%), th
inoculated group (log-rank test, P =0.0065).that cats are not susceptible to experimental infection with
a strain of SW/3/06 AIV.Pathogenicity in guinea pigs
To investigate replication of the SW/3/06 virus in guinea
pigs, ten animals were inoculated i.n. (n =5) or i.m. (n =5)
with 104.3 EID50 of SW/3/06 virus. Two animals from each
group were euthanized 3 dpi; nasal washes and the tra-
chea, lung, brain, kidney, spleen and colon were collected
from each animal for viral titration in ECEs. The virus was
detected in the nasal washes, tracheas and lungs of all ani-
mals inoculated i.n., but not in the nasal washes or tra-
cheas of animal inoculated i.m. (Table 4). The virus was
not detected in the brain, kidney, spleen or colon of any
inoculated animal (data not shown). The remaining three
animals in each group were observed for four weeks to de-
tect signs of disease. At 2, 3 and 4 weeks post-infection, all
animals had undergone seroconversion, as indicated by
the HI assay (Table 2). None of the animals showed signs
of disease during the period of observation. These results
indicate that replication of the SW/3/06 virus is restricted
to the respiratory system in guinea pigs.
For the transmission study, three animals were inocu-
lated i.n. with 106 EID50 of the SW/3/06 virus and three
naïve animals were introduced into the same cage 24 h
post-infection Evidence of transmission was based on
detection of virus in nasal washes and on seroconversion
at the end of the four-week observation period. The
virus was detected in the nasal washes of all inoculatedith the SW/3/06 virus. Eight-week-old specific pathogen-free Beagles
3/06 virus. (A) Body temperature after inoculation with SW/3/06 virus.
e i.t. inoculated group had significantly longer survival than the i.n.
Figure 4 Virus replication in beagles after inoculation with the H5N1 influenza virus strain SW/3/06. Tissue homogenates were prepared
from the animals that died post-infection with the SW/3/06 virus via either the i.n. or i.t route. Viral titers were determined in ECEs and expressed
as EID50 per gram for tissue samples and EID50 per ml for tracheal and cloacal swabs. The limits of virus detection (horizontal dotted lines) for
tissues and swabs were 1.75 and 0.75 log10 EID50, respectively (*P <0.05, ***P <0.001; two-way ANOVA followed by Tukey’s multiple
comparisons test).
Tabynov et al. Virology Journal 2014, 11:207 Page 6 of 13
http://www.virologyj.com/content/11/1/207guinea pigs between days 2–10 post-infection, but not in
any of the contact guinea pigs (Figure 6).
Seroconversion occurred in all inoculated animals; how-
ever, seroconversion was not observed in the contact
group (Table 2). These results indicate that the SW/3/06
virus does not transmit efficiently in this mammalian host.
Pathogenicity in pigs
Groups of 12-week-old piglets were i.n. (n =5) or i.m.
(n =5) inoculated with 105.3 EID50 of the SW/3/06 virus.
Five other pigs were mock-infected with PBS as controls.
No changes in food consumption or behavior were ob-
served in any inoculated animal. The body temperature of
the pigs inoculated with the SW/3/06 virus and the con-
trol animals remained with physiological norms (data not
shown).Figure 5 Macroscopic lung lesions in beagles infected with the SW/3/
virus on day 3 post-infection. Animals died 2.3 dpi. (B) Macroscopic lung le
Animals died 4.7 dpi.To detect the virus and determine infective titers, nasal
and rectal swabs were collected from the infected pigs.
The virus was not detected in any rectal swabs. However,
the virus was detected in nasal swabs taken on 1, 3, 5 and
7 dpi in all inoculated pigs (Figure 7). The viral titers of
the swabs taken from the animals in the i.n. inoculated
group were significantly higher than that of the i.m. inocu-
lated group (from P <0.01 to P <0.001; Figure 7). In gen-
eral, the H5N1 viral titers were similar in nasal samples
collected from the i.n. and i.m. inoculated groups on days
1, 3 and 5, and were higher than the titer of samples col-
lected on day 7 (P <0.01, Figure 7).
To determine the sites of virus replication, organ and
tissue samples (lungs, trachea, tonsils, nasal turbinate,
brain, heart, spleen, liver, kidney, adrenal glands) were
collected from the infected pigs on day 5 post-infection.06 virus. (A) Macroscopic lung lesion in a beagle infected i.n with the
sion in a beagle infected i.t. with the virus on day 5 post-infection.





Mean viral titer (log10 EID50/g)
a Seroconversion
(positive/total)cNasal washb Trachea Lung
I.n. (104.3) 2.2 ± 0.3 1.5 ± 0.7 3.6 ± 0.9 3/3
I.m. (104.3) – – 1.8 ± 0.2 3/3
aGroups of five guinea pigs were slightly anesthetized and inoculated
intranasally or intramuscularly with 104.3 EID50 of test virus (300 μl volume,
150 μl per nostril). Virus was not detected in the spleen, kidney, colon or brain
of any animal inoculated with the SW/3/06 virus; data not shown. –, virus not
detected in undiluted samples.
bLog10 EID50/ml.
cSeroconversion was determined on 14, 21, 28 dpi by the HI assay.
Figure 7 Viral titers of nasal swabs collected from pigs
inoculated with the SW/3/06 virus. Each data point and rhombus
represents the mean ± SEM viral titer (log10 EID50/ml of sample
media) for pigs positive for the influenza virus in Rapid Test Kit Н5
AIV Ag. Numbers of pigs shedding virus are shown in each point
and rhombus. The lower virus detection limit was 100.75 EID50/mL
(**P <0.01, ***P <0.001; two-way ANOVA followed by Tukey's multiple
comparisons test).
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inoculated pigs (Figure 8), namely the lungs, trachea,
tonsils and nasal turbinate; high viral titers were de-
tected in the lung, trachea and tonsils. The lung viral ti-
ters were significantly higher in the i.n. inoculated group
than the i.m. inoculated group (P <0.05; Figure 8). Low
virus accumulation was observed in the nasal turbinate
of pigs i.n. inoculated; however, the virus was not
detected in the nasal turbinate of pigs inoculated i.m.
(< 100.75 EID50/g; Figure 8). The HI assay demonstrated
all pigs infected with the SW/3/06 virus had undergone
seroconversion by 14, 21 and 28 dpi (Table 2). These re-
sults indicate that replication of the SW/3/06 virus is re-
stricted to the respiratory system in pigs.
Molecular determinants of virulence
Known molecular determinants of virulence for HPAI
H5N1 viruses (Additional file 1: Table S1) were identi-
fied in the genes encoding HA (N140S or D140S), PB1Figure 6 Transmission of the SW/3/06 virus in guinea pigs.
Three guinea pigs were inoculated i.n. with 106 EID50 of the SW/3/06
virus and, 24 h post-inoculation, three contact guinea pigs were
placed in each cage. Nasal washes were collected every two days
from all animals beginning 2 dpi for detection of virus shedding.
Numbers of guinea pigs shedding virus are shown in each point
and square. The lower virus limit detection was 100.75 EID50/mL.(L473V), PA (K237E, N383D), NS1 (D97E, V149A, C-
terminal ESEV motif ), M1 (N30D, T215A), M2 (cleavage
VDVD↓DG89) and NP (A184K) in the strain SW/3/06.
Other known molecular determinants of virulence were
not identified, including proteolytic cleavage site at posi-
tions 339–346 of HA (H5 numbering), the 20-amino-
acid deletion (positions 49–68) in the stalk region of
NA, the E627K or D701N mutations of PB2, the P42S
mutation of NS1, the M105V mutation of NP and the
other mutations shown in Additional file 1: Table S1.
However, these molecular determinants of virulenceFigure 8 Viral titers of tissues collected from pigs inoculated
with the SW/3/06 virus. Each bar represents the mean and range
viral titer (log10 EID50/gram of tissue) for tissues collected from three
pigs euthanized on day 5 post-inoculation. The limits of virus detection
(horizontal dotted lines) for tissues and swabs were 1.75 and 0.75 log10
EID50, respectively (*P <0.05; two-way ANOVA followed by Tukey’s
multiple comparisons test).
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strains that were isolated in Kazakhstan (Additional file 1:
Table S1).
The Kazakhstan strains SW/3/06, CK/6/05 and GS/1/05
all contain a glutamine residue at position 226 (H3 num-
bering) of HA, which has been associated with preferential
binding of sialic acid on the host cells joined to sugar
chains via an α-2,3 linkage; this mutation is typical of
HPAI H5N1 viruses (Additional file 2: Table S2). However,
the SW/3/06 strain also contained the mutations 228S
and 103S in the HA gene, which are absent in strains CK/
6/05 and GS/1/05. The 318I mutation of HA was also
present in all tested strains (Additional file 2: Table S2).
Discussion
Outbreaks of HPAI were recorded in four regions
of Kazakhstan (Pavlodar, Akmola, Karaganda, North
Kazakhstan) between July 22 and August 17, 2005. Four
strains of HPAI A/H5N1 viruses (GS/1/05, A/chicken/
Karaganda/4/05, A/chicken/NKO/5/05, CK/6/05) were
isolated from the epizootic nidus; these strains are related
to clade 2.2 of the Qinghai genotype [28,35-38]. The IVPI
of these strains in chickens ranges from 2.59-2.69, and the
strains cause 100% mortality in chickens within 2–4 days
of infection [27]. A second wave of outbreaks of HPAI was
registered on the coast of the Caspian Sea in March 2006.
The strain SW/3/06 (H5N1) was subsequently isolated
from autopsy materials collected from dead mute swans
found on Cape Peschannyi, 70 km from the city of Aktau
in the Mangistau region of Kazakhstan [26].
In this study, we examined a virus with a wild-bird ori-
gin, SW/3/06 (clade EA-nonGsGD), that does not pos-
sess the prime virulence determinant of HPAI H5N1
viruses: a polybasic HA cleavage site [Additional file 1:
Table S1]. However, the SW/3/06 virus is highly patho-
genic in chickens (IVPI =2.34) [27]; therefore, this strain
is a highly pathogenic. Therefore, we found it necessary
to examine the virulence of strain SW/3/06 in four spe-
cies of birds (chickens, ducks, turkeys, geese) and five
species of mammals (mice, guinea pigs, cats, dogs, pigs),
and furthermore, identify the molecular determinants of
virulence in the11 genes of this strain (HA, NA, PB1,
PB1-F2, PB2, PA, NS1, NS2, M1, M2 and NP).
Previous studies showed that H5N1 AIVs have varied
pathogenic potential in avian and mammalian species,
ranging from the complete absence of clinical disease to
severe neurological dysfunction and death [39,40]. This
study demonstrated that the SW/3/06 virus replicated
readily in three bird species (chickens, ducks, turkeys)
inoculated i.n. or i.m., causing 100% mortality within
1.6–5.2 days. High titers of virus were shed from both
the gastrointestinal and respiratory tracts of chickens
and turkeys on day 3 post-infection; high titers were also
detected in the lung, kidney and brain tissues. However,the viral titers of ducks and geese, in which a mild sys-
temic infection was observed, were lower compared to
those of chickens and turkeys. In addition, no mortalities
were observed in geese infected i.n. or i.m., and virus was
not detected in the brain of any goose. Previous reports
have suggested that domestic geese (Anser domesticus)
played a key role in the evolution of Asian-lineage HPAI
H5N1 viruses [41]. As geese vaccinated with inactivated
H5N1 vaccines do not appear to develop prolonged, high-
level immunity under experimental conditions without ex-
posure to multiple, high doses of the vaccine [42], this spe-
cies has the potential to play a role in viral persistence and
spread if vaccination programs are irregularly employed,
especially if lower doses than those recommended for
chickens are used. This study showed that geese shed the
virus without exhibiting any clinical signs, suggesting that
geese may play an important role in the transmission of
HPAI H5N1 viruses.
We also evaluated the susceptibility of dogs to H5N1
viral infection using beagles. The results demonstrate
that dogs (beagles) are highly susceptible to the H5N1
influenza virus and may potentially serve as an inter-
mediate host to transfer this virus to humans. Previous
studies reported limited viral shedding and an inability
to re-isolate virus from the organs of dogs experimen-
tally inoculated with H5N1 viruses [43,44]. Songserm
et al. [45] reported that an H5N1 influenza virus was de-
tected in multiple organs of a dog that died from eating
duck carcasses infected with H5N1 virus. However, in
this study, efficient virus replication was detected in the
respiratory system of all animals and viral shedding was
detected in all i.n. and i.t. inoculated animals, in agree-
ment with data obtained by Chen et al. in dogs infected
i.n. [46]. The ability of H5N1 influenza viruses to repli-
cate in dogs may vary from strain to strain, as observed
in our previous study [47], in which dogs were not sensi-
tive to experimental viral challenge with CK/6/05 (clade
2.2). This study demonstrates that the strain SW/3/06
can replicate much more efficiently in dogs than the
strains tested by other researchers [42,43]. Therefore, ef-
fort should be made to prevent dogs from being infected
by H5N1 influenza viruses to avoid the generation of a
virus with pandemic potential in this host.
The virus strains circulating in Asia could possibly
have a higher pathogenicity in cats than the strains of
the European lineage [48]. Our results demonstrated that -
in contrast to dogs -domesticated cats are not sensitive to
infection with H5N1. It is possible that the insensitivity of
cats to experimental infection with the SW/3/06 strain is
associated with the origin of this strain, which presumably
entered Kazakhstan from Europe (Sweden) via the Black
Sea/Mediterranean migration routes of birds [49]. How-
ever, our previous studies [50] indicated that the strain A/
chicken/NKO/5/05 (clade 2.2 of the Qinghai genotype)
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cats; the clinical signs and results of pathological analysis
of cats in our study of strain SW/3/06 (H5N1) were similar
to those of an experimental study conducted in 2004 by
Kuiken et al. [51].
Guinea pigs have been successfully employed as
models to evaluate the transmissibility of AIV strains
and other influenza viruses in mammalian hosts [52].
Our transmissibility study indicates that the SW/3/06
AIV strain does not transmit efficiently in this mamma-
lian host. Replication of the SW/3/06 virus was re-
stricted to the respiratory system in guinea pigs and
none of the animals showed any signs of disease. How-
ever, the presence of the virus in the nasal washes, tra-
chea and lungs of all animals inoculated i.n. suggests
that the guinea pig is worthy of further exploration as an
animal model for studying the nonlethal respiratory in-
fections induced by some HPAI H5N1 viruses.
This study indicated that HPAI H5N1 viruses can rep-
licate in Large White piglets; however, these animals had
a low susceptibility to infection. Infected Large White
pigs shed higher viral titers than Landrace-Large White
cross piglets inoculated with H5N1 viruses (clade 1,
clade 2.1, clade 2.2 and clade 2.3), and the time of shed-
ding (7 dpi) and viral titers of the lungs, trachea and
tonsils were similar to that of Landrace-Large White
cross piglets infected with H1N1 and H3N2 swine influ-
enza viruses, as reported by Lipatov et al. [53]. Addition-
ally, seroconversion occurred in all i.n. and i.m. infected
pigs. These results indicate that H5N1 AIVs can be
transmitted to pigs, which may increase the risk of these
viral genes being transmitted into humans.
The SW/3/06 virus replicated efficiently in chickens,
ducks, turkeys, mice and dogs. However, the amino acid
mutations in the protein PB2, NS1, NP, HA, and NA
that are known to contribute to the pathogenicity of HPAI
H5N1 viruses in birds and mammals ([23], Additional
file 1: Table S1) were not observed in this strain. However,
we identified 11 mutations in seven genes (HA, N140S or
D140S); PB1 (L473V); PA (K237E, N383D); NS1 (D97E,
V149A, C-terminal ESEV motif); M1 (N30D, T215A); M2
(cleavage VDVD↓DG89); NP (A184K)) in the strain SW/
3/06 ([6,11,20,22,24], Additional file 1: Table S1); these
mutations are likely to play a role in the pathogenicity
of the SW/3/06 strain in chickens, ducks, turkeys, mice
and dogs.
The HA gene of the SW/3/06 strain also contains the
228S mutation, which has been associated with switching
from SA-α-2,3-Gal to SA-α-2,6-Gal host receptor specifi-
city ([54], Additional file 2: Table S2), as well as the 103S
mutation; these mutations are absent in the strains CK/6/
05 and GS/1/05. The HA 318I mutation, which is asso-
ciated with reduced binding to avian-type receptors and
increased binding to human-type receptors, was also inpresent in all strains tested [Additional file 2: Table S2]. It
is possible that - either together or separately - the 228S-
103S-318I mutations in the HA gene play an important
role in the efficient replication of the SW/3/06 strain in
mammals (mice, dogs, pigs).
In summary, we have described the pathogenicity of
the newly-isolated HPAI H5N1 viral strain SW/3/06 in
birds and mammals, and explored the role of molecular
determinants of virulence in different genes. Additional
research to obtain mutant strains using reverse genetics
is required in order to fully characterize the role of the
mutations identified in the genes of strain SW/3/06;
these studies may help to identify key virulence or adap-
tation markers that can be used for global surveillance
of viruses threatening to emerge into the human popula-
tion. In addition, such research may provide insights into
new opportunities to combat such cross-species transfer




Studies of HPAI H5N1 viruses were conducted in a bio-
security level 3 laboratory approved by the Ministry of
Health of the Republic of Kazakhstan. Animal experi-
ments were conducted according to protocols approved
by the Institutional Animal Care and Use Committee
based on applicable laws and guidelines (Permit Num-
ber: 07/10/177). Animals were housed in conventional
animal facilities and received water and food ad libitum.
Virus
The A/swan/Mangistau/3/06 (SW/3/06) virus was isolated
from the pathological materials (trachea, lung, intestine,
brain) of a dead mute swan found in the Mangistau re-
gion, Kazakhstan [26]. The virus was propagated in 10-
day-old specific-pathogen-free (SPF) embryonated chicken
eggs (ECEs) for 60 h at 35°C and then stored at −70°C.
Animal experiments
Intravenous pathogenicity index test
The intravenous pathogenicity index (IVPI) of the AIV
isolates was determined as described in the OIE Manual
of Standards for Diagnostic Tests and Vaccines [32].
Pathogenicity studies in birds
An intranasal (i.n.) and intramuscular (i.m.) inoculation
study was conducted to determine the pathogenicity of
the virus in four types of birds. Twelve 6-week-old
White Leghorn chickens (G. gallus domesticus), twelve
6-week-old Kholmogory geese (Anser anser), twelve 6-
week-old Silver Bantam ducks (Anas platyrhyncos) and
12 four-week-old Czech turkeys (Meleagris gallopavo)
were inoculated i.n. or i.m. with 104.3 EID50 of the SW/
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Tracheal and cloacal swabs were collected on day 3
post-infection and examined for the presence of influ-
enza virus using Rapid Test Kit Н5 AIV Ag (Animal
Genetics, Inc., Suwon-si, Korea). Sera were collected at 2
and 3 weeks post-infection and at the end of the experi-
ment (4 weeks post-infection).
Three clinically normal birds from each group of geese
were euthanized on day 3 post-infection by administration
of sodium pentobarbital (100 mg/kg body weight i.v.). In
addition, all chicken, ducks and turkeys that died were
pathologically evaluated for gross lesions and tissue
samples (lung, brain, kidney) were collected for virus
isolation. Tissues were weighed and homogenized in ster-
ile phosphate-buffered saline (PBS), and the infectivity of
the clarified homogenates was titrated in embryonated
chicken eggs (ECEs). For swab samples, the swab medium
was clarified before inoculation into ECEs.
Mouse inoculation experiments
Female, 5 to 6-week-old BALB/c mice (Charles River
Laboratories, Sulzfeld, Germany; five per group) were in-
oculated i.n. or i.m. with 104.0 EID50 of virus in a volume
of 0.05 mL under light anesthesia induced using Zoletil
(Virbac S.A., La Seyne-sur-Mer, France). The viral titers
in the kidney, liver, spleen, lung and brain were exam-
ined in three dead mice from each group. The tissues
were collected, homogenized in 1 mL PBS, centrifuged,
the supernatant was diluted 1:10 and virus replication
was titrated in ECEs. To determine the mean mouse le-
thal dose (MLD50) and the 50% mouse infectious dose
(MID50), eight 6-week-old mice per group were inocu-
lated i.n. with 0.0 to 107.0 EID50/50 μl of 10-fold serially-
diluted SW/3/0610 virus. For MID50, lung tissues were
sampled from three mice euthanized days 2 post-
inoculation per group, and virus replication in the tissue
homogenates was determined in ECEs. The remaining
five mice per group were observed for 14 days to deter-
mine the MLD50; MLD50 was calculated using the
method of Reed & Muench [55].
Dog inoculation experiments
Eight to twelve-week-old Beagle dogs (n =9; Biotest S.r.o.,
Konárovice, Czech Republic) were serologically tested
using the HI assay with 0.5% chicken red blood cells
(CRBCs); all dogs were seronegative for H5 influenza vi-
ruses. The dogs were infected i.n. (n =3) or intratracheally
(i.t.; n =3) with 104.6 EID50 of SW/3/06 virus. Three other
dogs were mock-infected with PBS as controls. Rectal
body temperature was assessed every day for 5 dpi. Swabs
were collected from the trachea and rectum on day 2
post-infection, suspended in PBS, and used to inoculate
10-day-old ECEs to determine the log10 EID50/mL. Tra-
chea, lymph nodes, tonsil, brain and lung tissues werecollected from the dead dogs; the tissues of mock-infected
(control) dogs euthanized on day 5 post-infection were
also collected. Tissues were weighed, ground in sterile
PBS containing antibiotics to prepare 10% homogenates
and injected into 10 day-old ECEs for viral titration.
Cat inoculation experiments
Eight to twelve-week-old Scottish Fold cats (n =15; Scottish
Fold Cattery, Bellissimo, Republic of Kazakhstan) were
serologically tested using the HI assay with 0.5% CRBCs;
all animals were seronegative for H5 influenza viruses. The
cats were infected i.n. (n =5) or i.t. (n =5) with 104.6 EID50
of the SW/3/06 virus. Five other cats were mock-infected
with PBS as controls. Rectal body temperature was mea-
sured for 14 dpi. Swabs were collected from the trachea
and rectum every day, suspended in PBS, and used to in-
oculate White Leghorn 10-day-old ECEs to determine the
log10 EID50/mL. Clinical signs were observed for 28 days
after infection. Two cats from each group were euthanized
on day 5 post-infection via intravenous injection of T61
(0.3 mL/kg body weight; Intervet Ln, Millsboro, USA);
lung, brain, spleen, kidney, liver tissues were collected,
weighed, ground in sterile PBS containing antibiotics to
prepare 10% homogenates, and injected into 10 day-old
ECEs for viral titration. The remaining animals were ob-
served and serum samples were collected on 14, 21 and 28
dpi and analyzed using the HI assay with 0.5% CRBCs ac-
cording to standard procedures [33].
Guinea pig inoculation experiments
Female Hartley strain guinea pigs (Charles River Laborator-
ies, Wilmington, MA, USA) weighing 300–350 g that were
seronegative for influenza virus were used. Ketamine
(20 mg/kg) and xylazine (1 mg/kg) were used to anesthetize
the animals via i.n. or i.m. White Leghorn i.n. or i.m. with
104.3 EID50 of the SW/3/06 virus (volume, 300 μl; 150 μl
per nostril). Three animals from each group were eutha-
nized on day 3 post-infection and nasal washes, trachea,
lung, brain, kidney, spleen and colon tissue samples were
collected for viral titration in ECEs. The remaining two ani-
mals were observed for four weeks for signs of disease and
serum samples were collected on 14, 21, 28 dpi for the HI
assay using 0.5% CRBCs according to standard procedures
[33]. For contact transmission studies, groups of five ani-
mals were inoculated i.n. with 106 EID50 of the SW/3/06
virus and housed in cages placed inside an isolator. Five
naïve animals were introduced into the same cages 24 h
later. Nasal washes were collected at 2 day intervals, be-
ginning on day 2 post-infection (1 day post-contact) and
titrated in ECEs. To prevent inadvertent physical transmis-
sion of virus by the investigators, the contact guinea pigs
were always handled first, and gloves, implements and nap-
kins on the work surface were changed between animals.
The ambient conditions for these studies were 20–22°C
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was horizontal with a speed of 0.1 m/s.
Pig inoculation experiments
Twelve-week-old male castrated pigs (Large White) were
purchased from a local commercial farm. The pigs had
not received any vaccines on the production farm. In the
animal laboratory facilities, the pigs were housed in High
Efficiency Particulate Air (HEPA) filtered isolation units
and allowed to acclimatize for seven days. Piglets were fed
commercially-available pelleted diet in amounts prescribed
by the manufacturer to fulfill all dietary needs. Each virus
treatment group consisted of six pigs that were anesthe-
tized via i.m. injection of a ketamine (20 mg/kg) and xyla-
zine (2 mg/kg) mixture and inoculated i.n. or i.m. with a
dose 105.3 EID50 of virus. Six other pigs were mock-
infected with sterile PBS as controls. Body temperature
and feed consumption were monitored daily, starting
1 day before inoculation and ending on day 14 post-
infection.
Nasal and rectal swabs were collected 3 days before in-
fection and on days 1, 3, 5, 7, 9 and 14 post-infection.
Swabs were tested in 10 day-old ECEs to detect and ti-
trate the virus (lower detection limit, 100.75 EID50/mL).
Before titration, each sample of allantoic fluid that was
positive in a hemagglutination test was confirmed to be
influenza A/H5 virus positive using the Anigen Rapid
Test Kit Н5 AIV Ag (Animal Genetics, Inc., Suwon-si,
Korea). Viral titers were expressed as log10 EID50 per
1 mL of swab media. Three pigs from each group were
euthanatized on day 5 post-infection, and lung, trachea,
tonsil, nasal turbinate, brain, heart, spleen, liver, kidney,
adrenal gland samples were collected, weighed, ground
in sterile PBS containing antibiotics to prepare 10% ho-
mogenates, and injected into 10 day-old ECEs for virus
detection and titration.
Pigs were bled one day before and on day 14, 21 and 28
post-infection. To destroy non-specific inhibitors, the
serum samples were heat-inactivated at 56°C for 30 min
and then treated with 10% CRBCs for 60 min at 4°C. Serum
antibody titers were determined using the hemagglutination
inhibition (HI) assay with 0.5% CRBCs according to stand-
ard procedures [33].
Sequencing of complete genomes
Viral RNA was extracted from allantoic fluid using the
RNeasy mini kit (Qiagen, Valencia, CA, USA). RT-PCR
was performed to amplify gene segments of the SW/3/06
virus using a set of previously described universal primers
[56]. The PCR products were purified by agarose gel elec-
trophoresis and the Qiagen gel purification kit (Qiagen).
The nucleotide sequences of the HA (Genbank Accession
No.: FJ436942), NA (FJ436943), NS (JF262041), PA, PB1,
PB2, NP and MP (not yet published in GenBank) geneswere determined by dideoxy sequencing using an ABI
Genetic Analyser 3130xl (Applied Biosystems, Foster, CA,
USA).
Statistical analyses
Data were analyzed using Prism v.5.01 (GraphPad Software,
Inc., San Diego, CA, USA), and values are expressed as
the mean ± standard error of the mean. Kaplan-Meier sur-
vival rates were compared using the log rank test; two-way
ANOVA followed by Tukey’s multiple comparisons test
was used to analyze virus infectivity in the tissues and
swabs of infected birds and mammals. Statistical signifi-
cance was defined as P <0.05.
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